Restart Life Sciences Corp. (CSE:HEAL)
Canada flag Canada · Delayed Price · Currency is CAD
0.0500
+0.0050 (11.11%)
Apr 24, 2025, 4:00 PM EDT

Restart Life Sciences Statistics

Total Valuation

CSE:HEAL has a market cap or net worth of CAD 1.66 million. The enterprise value is 1.58 million.

Market Cap 1.66M
Enterprise Value 1.58M

Important Dates

The last earnings date was Tuesday, April 8, 2025.

Earnings Date Apr 8, 2025
Ex-Dividend Date n/a

Share Statistics

CSE:HEAL has 33.23 million shares outstanding. The number of shares has increased by 9.79% in one year.

Current Share Class n/a
Shares Outstanding 33.23M
Shares Change (YoY) +9.79%
Shares Change (QoQ) +20.73%
Owned by Insiders (%) 10.13%
Owned by Institutions (%) 3.15%
Float 29.86M

Valuation Ratios

The trailing PE ratio is 5.00.

PE Ratio 5.00
Forward PE n/a
PS Ratio n/a
PB Ratio -5.56
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 7.01
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.37

Current Ratio 0.37
Quick Ratio 0.37
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -353.47%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 209.39%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -66.67% in the last 52 weeks. The beta is 0.08, so CSE:HEAL's price volatility has been lower than the market average.

Beta (5Y) 0.08
52-Week Price Change -66.67%
50-Day Moving Average 0.08
200-Day Moving Average 0.11
Relative Strength Index (RSI) 40.25
Average Volume (20 Days) 38,912

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -626,217
Pretax Income 224,745
Net Income 224,745
EBITDA -623,906
EBIT -626,217
Earnings Per Share (EPS) 0.01
Full Income Statement

Balance Sheet

The company has 169,953 in cash and 83,931 in debt, giving a net cash position of 86,022 or 0.00 per share.

Cash & Cash Equivalents 169,953
Total Debt 83,931
Net Cash 86,022
Net Cash Per Share 0.00
Equity (Book Value) -299,071
Book Value Per Share -0.02
Working Capital -308,143
Full Balance Sheet

Cash Flow

Operating Cash Flow -71,773
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CSE:HEAL does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -9.79%
Shareholder Yield -9.79%
Earnings Yield 13.53%
FCF Yield n/a

Stock Splits

The last stock split was on January 24, 2025. It was a reverse split with a ratio of 0.5.

Last Split Date Jan 24, 2025
Split Type Reverse
Split Ratio 0.5

Scores

Altman Z-Score n/a
Piotroski F-Score n/a